Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02009839
Other study ID # NHG-SIG/05016
Secondary ID
Status Completed
Phase N/A
First received December 9, 2013
Last updated May 19, 2014
Start date July 2005
Est. completion date September 2007

Study information

Verified date May 2014
Source National Healthcare Group, Singapore
Contact n/a
Is FDA regulated No
Health authority Singapore: Domain Specific Review Boards
Study type Interventional

Clinical Trial Summary

The main aim of this study is to examine the effectiveness of a web-based CBT protocol (entitled Meeky Mouse) in the treatment of children with Selective Mutism in Singapore. The researchers hypothesized that the Meeky Mouse program would be associated with higher frequency of speaking behaviors, lower levels of anxiety, greater improvements in clinician-rated severity of mental illness, and higher clinician-rated improvement scores at post-treatment.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date September 2007
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender Both
Age group 6 Years to 12 Years
Eligibility Inclusion Criteria:

- 6-12 years old

- primary clinical diagnosis of Selective Mutism

- confirmed diagnosis of Selective Mutism by structured clinical parent interview

- fluent in English

Exclusion Criteria:

- below average intellectual functioning

- the presence of autism and schizophrenia

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Meeky Mouse program

Other:
Computer Games


Locations

Country Name City State
Singapore Child Guidance Clinic Singapore

Sponsors (1)

Lead Sponsor Collaborator
National Healthcare Group, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Selective Mutism Questionnaire Changes from pre-treatment (Week 0) to post-treatment (Week 14) on SMQ scores No
Secondary Asian Children's Anxiety Scale-Caretaker Version (ACAS) Changes from pre-treatment (Week 0) to post-treatment (Week 14) on ACAS total scores No
Secondary Asian Children's Anxiety Scale-Child (ACAS-C) Changes from pre-treatment (Week 0) to post-treatment (Week 14) on ACAS-C total scores No
Secondary Clinical Global Impression (CGI) Changes from pre-treatment (Week 0) to post-treatment (Week 14) on CGI-Severity and CGI-Improvement Ratings No
See also
  Status Clinical Trial Phase
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00554749 - What Treatment Works for Children With Selective Mutism? N/A
Completed NCT04585048 - The Efficacy of Integrated Behavioral Therapy for Selective Mutism N/A
Completed NCT04291638 - Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism N/A
Completed NCT01002196 - Randomised Controlled Treatment Study of Selective Mutism Phase 2
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Completed NCT02051192 - Brief Behavioral Treatment for Anxiety in Young Children Phase 1/Phase 2
Completed NCT00458198 - Integrated Behavioral Therapy for Treating Children With Selective Mutism N/A
Completed NCT05378711 - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine Phase 2
Completed NCT03612102 - Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism N/A
Completed NCT04233905 - Factors Influencing Selective Mutism